Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Simulations Plus
SLP
$371M
| $15.9M | 0.01% |
558,100
-46,400
| -8% | -$1.12M |
|
|
BBT
1102
Beacon Financial Corp
BBT
$2.5B
| $15.9M | 0.01% |
506,823
+12,823
| +3% | +$383K |
|
1103
IDEX
IEX
$17B
| $15.9M | 0.01% |
+92,225
| New | +$14.5M |
|
|
PARAA
1104
DELISTED
Paramount Global Class A
PARAA
| $15.9M | 0.01% |
316,800
+5,600
| +2% | +$277K |
|
1105
Evolution Petroleum
EPM
$133M
| $15.8M | 0.01% |
2,211,488
+121,000
| +6% | +$817K |
|
1106
RB Global
RBA
$21.5B
| $15.8M | 0.01% |
475,700
-133,400
| -22% | -$4.56M |
|
1107
Realty Income
O
$61.1B
| $15.8M | 0.01% |
236,399
+135,676
| +135% | +$9.27M |
|
1108
CytomX Therapeutics
CTMX
$690M
| $15.8M | 0.01% |
1,407,000
+116,400
| +9% | +$1.22M |
|
|
BERY
1109
DELISTED
Berry Global Group, Inc.
BERY
| $15.8M | 0.01% |
326,631
-690,209
| -68% | -$33.3M |
|
1110
Mitsubishi UFJ Financial
MUFG
$247B
| $15.8M | 0.01% |
3,315,700
+2,534,800
| +325% | +$12.2M |
|
1111
Kilroy Realty
KRC
$4.59B
| $15.7M | 0.01% |
212,900
-98,639
| -32% | -$7.5M |
|
1112
Hartford Financial Services
HIG
$39.9B
| $15.7M | 0.01% |
281,022
-413,500
| -60% | -$21.8M |
|
|
EIGI
1113
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $15.6M | 0.01% |
3,252,979
+201,500
| +7% | +$1.09M |
|
1114
NextEra Energy
NEE
$184B
| $15.6M | 0.01% |
304,400
+274,000
| +901% | +$13.5M |
|
1115
Belden
BDC
$3.97B
| $15.6M | 0.01% |
261,593
+243,993
| +1,386% | +$14M |
|
|
TMX
1116
DELISTED
Terminix Global Holdings, Inc.
TMX
| $15.5M | 0.01% |
298,400
-45,400
| -13% | -$2.34M |
|
|
WSR
1117
DELISTED
Whitestone REIT
WSR
| $15.5M | 0.01% |
1,219,100
+31,100
| +3% | +$390K |
|
1118
Ingredion
INGR
$6.42B
| $15.5M | 0.01% |
187,500
-130,200
| -41% | -$11.2M |
|
1119
Grupo Aeroportuario del Sureste
ASR
$8.16B
| $15.5M | 0.01% |
95,399
+20,744
| +28% | +$3.39M |
|
1120
Rafael Holdings
RFL
$103M
| $15.5M | 0.01% |
545,073
-39,323
| -7% | -$677K |
|
|
CLCT
1121
DELISTED
Collectors Universe
CLCT
| $15.4M | 0.01% |
722,038
-4,825
| -0.7% | -$92.2K |
|
|
SVA
1122
DELISTED
Sinovac Biotech, Ltd
SVA
| $15.4M | 0.01% |
2,375,841
| – | – |
|
1123
Mueller Water Products
MWA
$3.94B
| $15.4M | 0.01% |
1,564,300
-160,900
| -9% | -$1.61M |
|
1124
Manhattan Associates
MANH
$12.1B
| $15.3M | 0.01% |
221,260
-60,100
| -21% | -$3.87M |
|
1125
Freshpet
FRPT
$3.04B
| $15.3M | 0.01% |
336,200
-44,900
| -12% | -$2.03M |
|
Similar funds
Renaissance Technologies's Q2 2019 Portfolio in Review
As of Q2 2019, Renaissance Technologies held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Renaissance Technologies's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Renaissance Technologies's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Renaissance Technologies added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Renaissance Technologies's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Renaissance Technologies fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Renaissance Technologies's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Renaissance Technologies opened 495 new positions and closed 397 in Q2 2019.
- Renaissance Technologies's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.